Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Surgical management of medication-related osteonecrosis of the jaw: a retrospective study of Mronj patients

´ëÇÑÀΰøÄ¡¾Æ°ñÀ¯ÂøÇÐȸÁö 2021³â 13±Ç 1È£ p.36 ~ 41
½Å¿øÅÃ, ¾ç¿ø¼®, ±èÇ念, ¹ÚÁ¤Çö, ±èÁø¿ì, ±è¼±Á¾,
¼Ò¼Ó »ó¼¼Á¤º¸
½Å¿øÅà( Shin Won-Tack ) - Ewha Womans University Medical Center Department of Oral and Maxillofacial Surgery
¾ç¿ø¼® ( Yang Won-Soek ) - Ewha Womans University Medical Center Department of Oral and Maxillofacial Surgery
±èÇ念 ( Kim Heon-Young ) - Ewha Womans University Medical Center Department of Oral and Maxillofacial Surgery
¹ÚÁ¤Çö ( Park Jung-Hyun ) - Ewha Womans University Medical Center Department of Oral and Maxillofacial Surgery
±èÁø¿ì ( Kim Jin-Woo ) - Ewha Womans University Medical Center Department of Oral and Maxillofacial Surgery
±è¼±Á¾ ( Kim Sun-Jong ) - Ewha Womans University Medical Center Department of Oral and Maxillofacial Surgery

Abstract


Treatment for patients with Mronj vary according to stage. Purpose of this study is to inform the effectiveness of surgical treatment on Mronj stage 2 and 3 patients. We investigated the success rates and treatment outcomes of two stages of Mronj patients who received surgical treatment from March 2019 to May 2021 at Oral and Maxillofacial Surgery Department, Ewha Womans University Seoul Hospital. Total of 55 patients who underwent surgical treatment were studied. Data was collected by analyzing clinical and radiological findings. Of the 54 patients observed, 36 stage 2 patients ended treatment within six months of surgery and 4 out of 18 stage 3 patients went through another surgery. From the study, we could conclude that treating Mronj patients with aggressive surgical intervention properly enables reconstruction of settled oral environment.

Å°¿öµå

Mronj; Surgical treatment; Bone morphogenic protein

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸